Higher Adherence to the Mediterranean Dietary Pattern Is Inversely Associated With Severity of COVID-19 and Related Symptoms: A Cross-Sectional Study.
COVID-19
Mediterranean diet
dietary pattern
infectious disease
severe disease
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
04
2022
accepted:
20
06
2022
entrez:
5
8
2022
pubmed:
6
8
2022
medline:
6
8
2022
Statut:
epublish
Résumé
Adherence to the Mediterranean diet (MD) has been associated with a decreased risk of developing a variety of chronic diseases that are comorbidities in COVID-19 patients. However, its association to the severity and symptoms of COVID-19 are still unknown. This study aimed to examine the association between adherence to the MD pattern and COVID-19 severity and symptoms in Iranian hospitalized patients. In this cross-sectional study, 250 COVID-19 patients aged 18 to 65 were examined. We employed a food frequency questionnaire (FFQ) to obtain data on dietary intake of participants in the year prior to their COVID-19 diagnosis. COVID-19 severity was determined using the National Institutes of Health's Coronavirus Disease 2019 report. Additionally, symptoms associated with COVID-19, inflammatory markers, and other variables were evaluated. The scoring method proposed by Trichopoulou et al. was used to assess adherence to the MD. The participants' mean age was 44.1 ± 12.1 years, and 46% of them had severe COVID-19. Patients who adhered more closely to the MD had lower serum C-reactive protein levels (7.80 vs. 37.36 mg/l) and erythrocyte sedimentation rate (14.08 vs. 42.65 mm/h). Those with the highest MD score were 77% less likely to have severe COVID-19 after controlling for confounding variables. The MD score was also found to be inversely associated with COVID-19 symptoms, including dyspnea, cough, fever, chills, weakness, myalgia, nausea and vomiting, and sore throat. Higher adherence to the MD was associated with a decreased likelihood of COVID-19 severity and symptoms, as well as a shorter duration of hospitalization and convalescence, and inflammatory biomarkers.
Sections du résumé
Background and Aims
UNASSIGNED
Adherence to the Mediterranean diet (MD) has been associated with a decreased risk of developing a variety of chronic diseases that are comorbidities in COVID-19 patients. However, its association to the severity and symptoms of COVID-19 are still unknown. This study aimed to examine the association between adherence to the MD pattern and COVID-19 severity and symptoms in Iranian hospitalized patients.
Methods
UNASSIGNED
In this cross-sectional study, 250 COVID-19 patients aged 18 to 65 were examined. We employed a food frequency questionnaire (FFQ) to obtain data on dietary intake of participants in the year prior to their COVID-19 diagnosis. COVID-19 severity was determined using the National Institutes of Health's Coronavirus Disease 2019 report. Additionally, symptoms associated with COVID-19, inflammatory markers, and other variables were evaluated. The scoring method proposed by Trichopoulou et al. was used to assess adherence to the MD.
Results
UNASSIGNED
The participants' mean age was 44.1 ± 12.1 years, and 46% of them had severe COVID-19. Patients who adhered more closely to the MD had lower serum C-reactive protein levels (7.80 vs. 37.36 mg/l) and erythrocyte sedimentation rate (14.08 vs. 42.65 mm/h). Those with the highest MD score were 77% less likely to have severe COVID-19 after controlling for confounding variables. The MD score was also found to be inversely associated with COVID-19 symptoms, including dyspnea, cough, fever, chills, weakness, myalgia, nausea and vomiting, and sore throat.
Conclusion
UNASSIGNED
Higher adherence to the MD was associated with a decreased likelihood of COVID-19 severity and symptoms, as well as a shorter duration of hospitalization and convalescence, and inflammatory biomarkers.
Identifiants
pubmed: 35928288
doi: 10.3389/fmed.2022.911273
pmc: PMC9343686
doi:
Types de publication
Journal Article
Langues
eng
Pagination
911273Informations de copyright
Copyright © 2022 Zargarzadeh, Tadbir Vajargah, Ebrahimzadeh, Mousavi, Khodaveisi, Akhgarjand, Toyos, Cerqueira, Santos, Taghizadeh and Milajerdi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):624-632
pubmed: 28684083
Diseases. 2021 Oct 29;9(4):
pubmed: 34842636
Nutrients. 2021 Jan 30;13(2):
pubmed: 33573169
J Nutr Biochem. 2016 Oct;36:1-20
pubmed: 27692243
Curr Nutr Rep. 2021 Dec;10(4):364-374
pubmed: 34837637
Metabolism. 2012 Apr;61(4):577-82
pubmed: 22075273
Br J Nutr. 2006 Nov;96 Suppl 2:S46-51
pubmed: 17125533
Nutrients. 2020 Mar 03;12(3):
pubmed: 32138220
Eur J Clin Nutr. 2011 Jun;65(6):703-10
pubmed: 21407247
Complement Ther Med. 2020 Mar;49:102358
pubmed: 32147056
Ann Intern Med. 2006 Jul 4;145(1):1-11
pubmed: 16818923
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
WMJ. ;115(6):317-21
pubmed: 29094869
Nutr Diabetes. 2018 Mar 9;8(1):13
pubmed: 29549354
Front Nutr. 2022 Apr 13;9:833628
pubmed: 35495923
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154
pubmed: 32602883
Angiology. 2015 Apr;66(4):304-18
pubmed: 24778424
J Pers Med. 2020 Sep 25;10(4):
pubmed: 32992693
Rev Environ Health. 2021 Jul 29;37(1):29-33
pubmed: 34332516
Am J Clin Nutr. 2021 Jul 1;114(1):257-266
pubmed: 33742193
Medicina (Kaunas). 2021 Dec 20;57(12):
pubmed: 34946334
Clin Ther. 2021 Dec;43(12):e346-e363
pubmed: 34857394
Nutrients. 2020 May 19;12(5):
pubmed: 32438620
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
JAMA Netw Open. 2021 Feb 1;4(2):e210369
pubmed: 33576820
Toxicol Ind Health. 2014 Sep;30(8):738-49
pubmed: 23104728
Hum Nutr Clin Nutr. 1985;39 Suppl 1:5-41
pubmed: 4044297
mSystems. 2021 Dec 21;6(6):e0023321
pubmed: 34726496
J Biol Chem. 2001 May 18;276(20):16683-9
pubmed: 11278967
Metabolism. 2021 Jan;114:154407
pubmed: 33080270
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Arch Intern Med. 2007 Jun 11;167(11):1195-1203
pubmed: 17563030
Front Public Health. 2021 Dec 16;9:760795
pubmed: 34976922
Adv Nutr. 2015 May 15;6(3):293S-301S
pubmed: 25979502
Am J Clin Nutr. 2020 Jul 1;112(1):13-18
pubmed: 32491173
Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):50-60
pubmed: 25940230
Front Nutr. 2022 Apr 29;9:837458
pubmed: 35571931
Maturitas. 2020 Feb;132:65-69
pubmed: 31883665
Public Health Nutr. 2010 May;13(5):654-62
pubmed: 19807937
Rev Clin Esp (Barc). 2021 Jan;221(1):55-61
pubmed: 33998479
Med Clin (Barc). 2021 Oct 22;157(8):388-394
pubmed: 34140166
JAMA. 2021 Mar 16;325(11):1053-1060
pubmed: 33595634
BMJ Nutr Prev Health. 2021 Jun 07;4(1):257-266
pubmed: 34308134
Br J Clin Pharmacol. 2017 Jan;83(1):114-128
pubmed: 27100393
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Nutrients. 2020 Dec 16;12(12):
pubmed: 33339084
Crit Rev Food Sci Nutr. 2021;61(3):417-430
pubmed: 32126807
Nutr Res. 2013 Dec;33(12):1012-8
pubmed: 24267040
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):953-9
pubmed: 23332727
PLoS Pathog. 2016 Dec 15;12(12):e1005973
pubmed: 27977798
Nutrients. 2017 Dec 02;9(12):
pubmed: 29207471
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):293-306
pubmed: 34511220
Front Cell Infect Microbiol. 2022 Jan 05;11:792584
pubmed: 35096645
Nutrients. 2020 Aug 04;12(8):
pubmed: 32759636
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
Pharmaceuticals (Basel). 2020 Sep 08;13(9):
pubmed: 32911682
Eur J Pharmacol. 2018 Sep 5;834:10-16
pubmed: 30012497
Pharmacol Res. 2012 Jun;65(6):577-83
pubmed: 22449789